BG
EW icon

Bahl & Gaynor’s Edwards Lifesciences EW Stock Holding History

Bahl & Gaynor’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Hold
5,098
– – ﹤0.01% 291
2026
Q1 		$408K Sell
5,098
-450
-8% -$37.1K ﹤0.01% 290
2025
Q4 		$473K Buy
5,548
+450
+9% +$36.9K ﹤0.01% 288
2025
Q3 		$396K Hold
5,098
– – ﹤0.01% 296
2025
Q2 		$399K Hold
5,098
– – ﹤0.01% 297
2025
Q1 		$370K Hold
5,098
– – ﹤0.01% 306
2024
Q4 		$377K Hold
5,098
– – ﹤0.01% 300
2024
Q3 		$336K Hold
5,098
– – ﹤0.01% 310
2024
Q2 		$471K Hold
5,098
– – ﹤0.01% 284
2024
Q1 		$487K Sell
5,098
-197
-4% -$16.5K ﹤0.01% 286
2023
Q4 		$404K Buy
+5,295
New +$368K ﹤0.01% 294
2023
Q3 		– Sell
-3,194
Closed -$301K – 339
2023
Q2 		$301K Buy
3,194
+164
+5% +$14.3K ﹤0.01% 309
2023
Q1 		$251K Sell
3,030
-335
-10% -$26.3K ﹤0.01% 317
2022
Q4 		$251K Buy
3,365
+193
+6% +$14.9K ﹤0.01% 314
2022
Q3 		$262K Buy
+3,172
New +$305K ﹤0.01% 301
2022
Q2 		– Sell
-2,314
Closed -$272K – 330
2022
Q1 		$272K Buy
2,314
+190
+9% +$21.3K ﹤0.01% 317
2021
Q4 		$275K Hold
2,124
– – ﹤0.01% 313
2021
Q3 		$240K Hold
2,124
– – ﹤0.01% 324
2021
Q2 		$220K Buy
+2,124
New +$200K ﹤0.01% 333

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bahl & Gaynor's EW Position: Q2 2026 in Review

Bahl & Gaynor held its Edwards Lifesciences (EW) position steady in Q2 2026 at 5,098 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #291.

Bahl & Gaynor first reported a position in EW in Q2 2021 and has held it in 19 quarters since. The position peaked at $487K in Q1 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bahl & Gaynor held 5,098 shares of Edwards Lifesciences worth $461K as of Q2 2026.
  • Bahl & Gaynor left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Bahl & Gaynor's portfolio in Q2 2026, its #291 holding.
  • Bahl & Gaynor first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 19 quarters since.
  • Bahl & Gaynor's Edwards Lifesciences position peaked at $487K in Q1 2024.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.